Smith Stan bought MAIA
March 14, 2024 · Form 4 insider transaction
Smith Stan bought 170,940 shares of MAIA Biotechnology, Inc. at $1.17 per share, a transaction worth $200.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
170,940
Price
$1.17
Total value
$200.0K
InsiderSmith Stan
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 14, 2024
Filing dateMarch 15, 2024
Shares owned after857,568
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.; These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.